These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
697 related articles for article (PubMed ID: 26771973)
1. Risk Factors of Parathyroid Dysfunction in Elderly Patients with Chronic Kidney Disease Undergoing Hemodialysis. Li W; Zhang S Adv Clin Exp Med; 2015; 24(6):1007-12. PubMed ID: 26771973 [TBL] [Abstract][Full Text] [Related]
2. Prevalence and determinants of parathyroid dysfunction in elderly patients on hemodialysis. Lu JR; Yi Y; Tian J; Xiong CX; Wang XH; Hu J; Chen XF Blood Purif; 2014; 37(2):119-24. PubMed ID: 24662249 [TBL] [Abstract][Full Text] [Related]
3. Lower serum fibroblast growth factor-23 levels may suggest malnutrition in maintenance haemodialysis patients. Mizuiri S; Nishizawa Y; Yamashita K; Ono K; Oda M; Usui K; Shigemoto K Nephrology (Carlton); 2014 Sep; 19(9):568-73. PubMed ID: 24947687 [TBL] [Abstract][Full Text] [Related]
4. The relationship between total mass and blood supply of parathyroid glands and their secretion of parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism. Ahmadi F; Aghajanzadeh P; Yazdi HR; Maziar S; Gatmiri SM Saudi J Kidney Dis Transpl; 2016 Mar; 27(2):263-9. PubMed ID: 26997379 [TBL] [Abstract][Full Text] [Related]
5. Relation between Calcium, Phosphorus, Calcium-Phosphorus Index and iPTH in Chronic Kidney Disease Patients. Adhikary LP; Yadava SK; Pokharel A; Khadka D; Thakur R J Nepal Health Res Counc; 2015; 13(29):50-3. PubMed ID: 26411713 [TBL] [Abstract][Full Text] [Related]
6. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study. Tentori F; Wang M; Bieber BA; Karaboyas A; Li Y; Jacobson SH; Andreucci VE; Fukagawa M; Frimat L; Mendelssohn DC; Port FK; Pisoni RL; Robinson BM Clin J Am Soc Nephrol; 2015 Jan; 10(1):98-109. PubMed ID: 25516917 [TBL] [Abstract][Full Text] [Related]
7. [Comparison of some nutritional parameters in hemodialysis patients over and below 65 years of age]. Bednarek-Skublewska A; Baranowicz-Gaszczyk I; Jóźwiak L; Dzik M; Majdan M; Ksiazek A Pol Arch Med Wewn; 2005 May; 113(5):417-23. PubMed ID: 16479823 [TBL] [Abstract][Full Text] [Related]
9. Vitamin D deficiency and associated factors in hemodialysis patients. Jean G; Charra B; Chazot C J Ren Nutr; 2008 Sep; 18(5):395-9. PubMed ID: 18721733 [TBL] [Abstract][Full Text] [Related]
10. Changes of serum calcium, phosphorus, and parathyroid hormone concentrations and ocular findings among patients undergoing hemodialysis. Pakdel F; Samimagham H; Shafaroodi A; Sheikhvatan M Saudi J Kidney Dis Transpl; 2011 Nov; 22(6):1142-8. PubMed ID: 22089771 [TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamics of evocalcet for secondary hyperparathyroidism in Japanese hemodialysis patients. Shigematsu T; Shimazaki R; Fukagawa M; Akizawa T; Clin Exp Nephrol; 2019 Feb; 23(2):258-267. PubMed ID: 30159688 [TBL] [Abstract][Full Text] [Related]
12. Association of Parameters of Mineral Bone Disorder with Mortality in Patients on Hemodialysis according to Level of Residual Kidney Function. Wang M; Obi Y; Streja E; Rhee CM; Lau WL; Chen J; Hao C; Hamano T; Kovesdy CP; Kalantar-Zadeh K Clin J Am Soc Nephrol; 2017 Jul; 12(7):1118-1127. PubMed ID: 28487345 [TBL] [Abstract][Full Text] [Related]
13. The Kidney Disease Outcomes Quality Initiative (K/DOQI) Guideline for Bone Metabolism and Disease in CKD: association with mortality in dialysis patients. Noordzij M; Korevaar JC; Boeschoten EW; Dekker FW; Bos WJ; Krediet RT; Am J Kidney Dis; 2005 Nov; 46(5):925-32. PubMed ID: 16253734 [TBL] [Abstract][Full Text] [Related]
14. Histopathological changes of radial artery wall in patients of chronic kidney disease stage 5 undergoing AV fistula formation and their correlation with serum iPTH levels. Tripathi V; Bansal S; Alok S; Ravi B; Devra AK; Saxena S Saudi J Kidney Dis Transpl; 2015 Sep; 26(5):884-9. PubMed ID: 26354558 [TBL] [Abstract][Full Text] [Related]
15. The Relation Between Variability of Intact Parathyroid Hormone, Calcium, and Cardiac Mortality in Hemodialysis Patients. Ulusoy S; Ozkan G; Guvercin B; Yavuz A Artif Organs; 2016 Nov; 40(11):1078-1085. PubMed ID: 27110947 [TBL] [Abstract][Full Text] [Related]
16. Predictors of short-term changes in serum intact parathyroid hormone levels in hemodialysis patients: role of phosphorus, calcium, and gender. Indridason OS; Pieper CF; Quarles LD J Clin Endocrinol Metab; 1998 Nov; 83(11):3860-6. PubMed ID: 9814459 [TBL] [Abstract][Full Text] [Related]
17. Parathyroid function as a determinant of the response to calcitriol treatment in the hemodialysis patient. Rodriguez M; Caravaca F; Fernandez E; Borrego MJ; Lorenzo V; Cubero J; Martin-Malo A; Betriu A; Jimenez A; Torres A; Felsenfeld AJ Kidney Int; 1999 Jul; 56(1):306-17. PubMed ID: 10411707 [TBL] [Abstract][Full Text] [Related]
18. Abnormal mineral metabolism and mortality in hemodialysis patients with secondary hyperparathyroidism: evidence from marginal structural models used to adjust for time-dependent confounding. Fukagawa M; Kido R; Komaba H; Onishi Y; Yamaguchi T; Hasegawa T; Kurita N; Fukuma S; Akizawa T; Fukuhara S Am J Kidney Dis; 2014 Jun; 63(6):979-87. PubMed ID: 24119541 [TBL] [Abstract][Full Text] [Related]
19. Secondary hyperparathyroidism is associated with pulmonary hypertension in older patients with chronic kidney disease and proteinuria. Genctoy G; Arikan S; Gedik O Int Urol Nephrol; 2015 Feb; 47(2):353-8. PubMed ID: 25537827 [TBL] [Abstract][Full Text] [Related]
20. High prevalence of secondary hyperparathyroidism in chronic kidney disease patients on dialysis in Argentina. Douthat WG; Castellano M; Berenguer L; Guzmán MA; de Arteaga J; Chiurchiu CR; Massari PU; Garay G; Capra R; de La Fuente JL Nefrologia; 2013; 33(5):657-66. PubMed ID: 24089157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]